NCT00993824View on ClinicalTrials.gov

Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 Diabetes

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Type 2 Diabetes
Interventions
DRUG

colesevelam HCl

3.75 grams of colesevelam HCl (6 tablets)

DRUG

placebo

Trial Locations (1)

55416

International Diabetes Center, Minneapolis

Sponsors

Collaborators (1)

Daiichi Sankyo
All Listed Sponsors
collaborator

International Diabetes Center at Park Nicollet

OTHER

collaborator

Daiichi Sankyo

INDUSTRY

lead

HealthPartners Institute

OTHER